六月 2026
eps.co.jp
显示 Similarweb 估计数据。
关联 GA4，公开验证您的网站指标
与您的成功同步
绑定 Google Analytics，验证您网站的流量及用户参与度指标
跳出率
40.97%
每次访问页数
4.44
平均访问时长
00:07:12
eps.co.jp的 10 大竞争对手
在 六月 2026 与 eps.co.jp 相似的前 10 名网站，按关键字流量、受众定位和市场重叠方面与 eps.co.jp 的关联性排名
Gain insight into the emerging platforms, regulatory shifts, and clinical advances that are redefining early-phase oncology.1. What is early-phase oncology and why is it important?Early-phase oncology represents the bridge between laboratory discovery and clinical validation by defining safety, dosing, PK/PD, and early efficacy. These studies form the foundation for advancing promising cancer treatments into broader development and eventual clinical use.
跳出率
42%
每次访问页数
2.12
平均访问时长
00:00:35
シミックグループは、日本におけるCRO（医薬品開発支援）のパイオニアとして、グループ独自の事業モデル「PVC: Pharmaceutical Value Creator」を展開し、開発から製造、営業・マーケティングなど、製薬企業のバリューチェーンをすべて支援できる体制を整えています。
跳出率
45.05%
每次访问页数
2.69
平均访问时长
00:01:50
Discover PPD's vaccine development and clinical trial management strategies that enable science and society to come together to protect public health.
- 公司
- PPD
跳出率
31.92%
每次访问页数
3.81
平均访问时长
00:04:34
相似度评分
95%Our Global Chief AI and Augmented Intelligence Officer, Matt Lewis, recently contributed to a Leveraging AI podcast on “The Chief AI Officer’s Guide to Practical AI Business Transformation”.
跳出率
45.23%
每次访问页数
2.49
平均访问时长
00:01:48
相似度评分
93%Allucent is a global, full-service CRO specializing in biotech & small-to-mid-size pharma. Get expert clinical research solutions & accelerate your development.
全球排名
- -
国家/地区排名
- -
品类排名
- -
跳出率
48.92%
每次访问页数
1.70
平均访问时长
00:00:46
Celerion is a leading clinical research organization providing early phase clinical research, bioanalytical services, and drug development expertise.
跳出率
58.09%
每次访问页数
1.54
平均访问时长
00:00:17
Partner with Crown Bioscience for CRO consulting services that bridge preclinical and clinical research. Our experts accelerate drug development success.
跳出率
37.45%
每次访问页数
2.39
平均访问时长
00:01:57
Inotiv has over 1,200 devoted employees in more than 20 locations across North America and Europe who provide our customers with mission-critical products and services to enable their critical research.
跳出率
42.02%
每次访问页数
2.03
平均访问时长
00:00:20
相似度评分
86%End to end drug discovery services, including hit ID, hit to lead, lead optimization and pharmacology, applying AI and utilizing decades of scientific expertise to deliver novel disease-modifying candidates. Our lab teams deliver high quality, decision ready data to help you advance therapies with confidence.
跳出率
29.32%
每次访问页数
6.45
平均访问时长
00:04:38
fully integrated cro/cdmo, with a 40-year track record of serving pharmaceutical and biotech companies.
跳出率
48.4%
每次访问页数
2.75
平均访问时长
00:04:18
相似度评分
84%eps.co.jp在 六月 2026 的前五名竞争对手是：novotech-cro.com、cmicgroup.com、ppdi.com、inizio.com等。
根据 Similarweb 的月访问量数据，eps.co.jp 在 六月 2026 的头号竞争对手是 novotech-cro.com。与 eps.co.jp 相似度排名第二的网站是 cmicgroup.com，排名第三的是 ppdi.com。
在 六月 2026，inizio.com 被评为与 eps.co.jp 相似度第四高的网站，allucent.com 位居第五。
进入前十名榜单的其他五家竞争对手分别是 celerion.com、crownbio.com、inotiv.com、q2labsolutions.com 和 nuvisan.com。